These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15819867)

  • 21. A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres.
    Adler A; Baraniak A; Izdebski R; Fiett J; Gniadkowski M; Hryniewicz W; Salvia A; Rossini A; Goossens H; Malhotra S; Lerman Y; Elenbogen M; Carmeli Y;
    Clin Microbiol Infect; 2013 Feb; 19(2):E51-8. PubMed ID: 23210906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence and molecular characterization of extended-spectrum β-lactamase-producing Proteus mirabilis strains in southern Croatia.
    Tonkić M; Mohar B; Šiško-Kraljević K; Meško-Meglič K; Goić-Barišić I; Novak A; Kovačić A; Punda-Polić V
    J Med Microbiol; 2010 Oct; 59(Pt 10):1185-1190. PubMed ID: 20558587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial Susceptibility and Molecular Epidemiology of
    Lin MF; Liou ML; Kuo CH; Lin YY; Chen JY; Kuo HY
    Microb Drug Resist; 2019 Nov; 25(9):1338-1346. PubMed ID: 31295061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.
    Fernández A; Gil E; Cartelle M; Pérez A; Beceiro A; Mallo S; Tomás MM; Pérez-Llarena FJ; Villanueva R; Bou G
    J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of Proteus mirabilis isolates producing TEM-52 extended-spectrum beta-lactamases in Croatia.
    Sardelić S; Bedenić B; Sijak D; Colinon C; Kalenić S
    Chemotherapy; 2010; 56(3):208-13. PubMed ID: 20551637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spread of novel expanded-spectrum beta-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France.
    Lartigue MF; Fortineau N; Nordmann P
    Clin Microbiol Infect; 2005 Jul; 11(7):588-91. PubMed ID: 15966981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community.
    Potron A; Hocquet D; Triponney P; Plésiat P; Bertrand X; Valot B
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities.
    Migliavacca R; Nucleo E; D'Andrea MM; Spalla M; Giani T; Pagani L
    New Microbiol; 2007 Jul; 30(3):295-8. PubMed ID: 17802913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Proteus mirabilis isolates in Taiwan.
    Huang CW; Chien JH; Peng RY; Tsai DJ; Li MH; Lee HM; Lin CF; Lee MC; Liao CT
    Int J Antimicrob Agents; 2015 Jan; 45(1):84-5. PubMed ID: 25446905
    [No Abstract]   [Full Text] [Related]  

  • 30. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.
    Yan JJ; Tsai SH; Chuang CL; Wu JJ
    J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan.
    Kanayama A; Kobayashi I; Shibuya K
    Int J Antimicrob Agents; 2015 Feb; 45(2):113-8. PubMed ID: 25182712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates.
    Nucleo E; Fugazza G; Migliavacca R; Spalla M; Comelli M; Pagani L; Debiaggi M
    New Microbiol; 2010 Jan; 33(1):37-45. PubMed ID: 20402412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of ESbetaL producing P. mirabilis strains from a long-term care and rehabilitation facility in Italy.
    Migliavacca R; Migliavacca A; Nucleo E; Ciaponi A; Spalla M; De Luca C; Pagani L
    New Microbiol; 2007 Jul; 30(3):362-6. PubMed ID: 17802927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
    Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
    J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
    Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
    J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
    Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
    J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional outbreak of CTX-M-2 β-lactamase-producing Proteus mirabilis in Japan.
    Nakano R; Nakano A; Abe M; Inoue M; Okamoto R
    J Med Microbiol; 2012 Dec; 61(Pt 12):1727-1735. PubMed ID: 22935848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
    Protonotariou E; Poulou A; Politi L; Meletis G; Chatzopoulou F; Malousi A; Metallidis S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2020 Aug; 56(2):106060. PubMed ID: 32574790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging extended-spectrum beta-lactamases in Proteus mirabilis.
    Pagani L; Migliavacca R; Pallecchi L; Matti C; Giacobone E; Amicosante G; Romero E; Rossolini GM
    J Clin Microbiol; 2002 Apr; 40(4):1549-52. PubMed ID: 11923394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.